704 related articles for article (PubMed ID: 19231117)
1. Progestogen deficiency and endometrial cancer risk.
Schindler AE
Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
[TBL] [Abstract][Full Text] [Related]
2. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
3. [Current views on the epidemiology and etiology of endometrial carcinoma].
Kaiser R; Schulz KD
Gynakologe; 1983 Jun; 16(2):82-6. PubMed ID: 6350118
[TBL] [Abstract][Full Text] [Related]
4. Oestrogens and endometrial hyperplasia.
Thom MH; Studd JW
Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
[TBL] [Abstract][Full Text] [Related]
5. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks R; Lukanova A; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
[TBL] [Abstract][Full Text] [Related]
6. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
7. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
8. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
Sturdee DW
Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
10. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
11. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
12. The role of hormones in the etiology and prevention of endometrial cancer.
Gambrell RD
Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826
[TBL] [Abstract][Full Text] [Related]
13. Endogenous and exogenous endocrine factors.
Henderson BE
Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
[TBL] [Abstract][Full Text] [Related]
14. Contraception for the perimenopausal patient.
Upton GV
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
Völker W; Kannengiesser U; Majewski A; Vasterling HW
Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
[TBL] [Abstract][Full Text] [Related]
16. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
17. Estrogens, progestogens and endometrial cancer.
Gambrell RD
J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
[TBL] [Abstract][Full Text] [Related]
18. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and endometrial cancer.
Emons G; Huschmand-Nia A; Krauss T; Hinney B
Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of ovarian function and reproduction for cancer development and prevention.
Schindler AE
Gynecol Endocrinol; 2011 Dec; 27(12):1043-7. PubMed ID: 21501003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
